Top stories in cardiology: Dapagliflozin reduces AF in high-risk patients, physical inactivity confers similar health risks to smoking
Click Here to Manage Email Alerts
Researchers found that high-risk patients with diabetes who were treated with dapagliflozin experienced a decrease in atrial fibrillation and atrial flutter incidences. It was the week’s top story in cardiology.
Another top story was about research that showed physical inactivity was associated with a similar risk for atherosclerotic cardiovascular disease (ASCVD) as smoking status and poor cholesterol.
Read these and more top stories in cardiology below:
Dapagliflozin reduces AF events in high-risk patients with diabetes
High-risk patients with diabetes who were treated with dapagliflozin had a decrease in the incidence of atrial fibrillation and atrial flutter, according to an analysis of the DECLARE-TIMI 58 trial published in Circulation. Read more.
Physical inactivity confers similar ASCVD risk to smoking status
Physical inactivity was associated with an excess risk for ASCVD similar to smoking and poor cholesterol levels, according to a research letter published in the European Journal of Preventive Cardiology. Read more.
ACC: Coronavirus has cardiac implications, especially in existing CVD
The American College of Cardiology released a bulletin on the cardiac implications of the coronavirus emphasizing the importance of advising patients with CVD on their potential increased risk for the virus. Read more.
Evolocumab lowers LDL in familial hypercholesterolemia
Evolocumab effectively lowered plasma LDL in patients with homozygous or severe heterozygous familial hypercholesterolemia, according to long-term data from the TAUSSIG trial published in the Journal of the American College of Cardiology. Read more.
Diabetic retinopathy confers stroke risk in diabetes
Among patients with diabetes, those with diabetic retinopathy had elevated stroke risk compared with those who did not, according to new data from the ACCORD Eye study presented at the International Stroke Conference. Read more.